PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme
CNS Neuroscience & Therapeutics · 2024-01 · 30 (1)
DOI: 10.1111/cns.14566 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 12.01.2024. Verfasst von Lijie Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Beijing Neurosurgical Institute, Capital Medical University, China. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Open Research Fund of the National Center for Protein Sciences at Peking University in Beijing, Beijing Nova Program.
Abstract (Originalsprache)
Aims
This study aimed to investigate the role of plasmacytoma variant translocation 1 (PVT1), a long non‐coding RNA, in glioblastoma multiforme (GBM) and its impact on the tumor microenvironment (TME).
Methods
We assessed aberrant PVT1 expression in glioma tissues and its impact on GBM cell growth in vitro and in vivo. Additionally, we investigated PVT1's role in influencing glioma‐associated macrophages. To understand PVT1's role in cell growth and the immunosuppressive TME, we performed a series of comprehensive experiments.
Results
PVT1 was overexpressed in GBM due to copy number amplification, correlating with poor prognosis. Elevated PVT1 promoted GBM cell proliferation, while its downregulation inhibited growth in vitro and in vivo. PVT1 inhibited type I interferon‐stimulated genes (ISGs), with STAT1 as the central hub. PVT1 correlated with macrophage enrichment and regulated CX3CL1 expression, promoting recruitment and M2 phenotype polarization of macrophages. PVT1 localized to the cell nucleus and bound to DHX9, enriching at the promoter regions of STAT1 and CX3CL1, modulating ISGs and CX3CL1 expression.
Conclusion
PVT1 plays a significant role in GBM, correlating with poor prognosis, promoting cell growth, and shaping an immunosuppressive TME via STAT1 and CX3CL1 regulation. Targeting PVT1 may hold therapeutic promise for GBM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, Beijing Neurosurgical Institute, Capital Medical University, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Department of Cell Biology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
- Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China.
- China National Clinical Research Center for Neurological Diseases, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Open Research Fund of the National Center for Protein Sciences at Peking University in Beijing
- Beijing Nova Program
Zitieren
APA
Huang, L., Wang, Z., Liao, C., Zhao, Z., Gao, H., Huang, R., Chen, J., Wu, F., Zeng, F., Zhang, Y., Jiang, T., & Hu, H. (2024). PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme. CNS Neuroscience & Therapeutics, 30(1). https://doi.org/10.1111/cns.14566
Vancouver
Huang L, Wang Z, Liao C, Zhao Z, Gao H, Huang R, et al. PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme. CNS Neuroscience & Therapeutics. 2024;30(1). doi:10.1111/cns.14566
BibTeX
@article{Huang2024,
author = {Huang, Lijie and Wang, Zheng and Liao, Chihyi and Zhao, Zheng and Gao, Hua and Huang, Ruoyu and Chen, Jing and Wu, Fan and Zeng, Fan and Zhang, Ying and Jiang, Tao and Hu, Huimin},
title = {PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {1},
doi = {10.1111/cns.14566}
}
EUVIMED